Human T-cell leukemia virus type I at age 25: A progress report

被引：24
作者：
Matsuoka, M
Jeang, KT
机构：
[1] Kyoto Univ, Inst Virus Res, Lab Virus Immunol, Kyoto 606, Japan
[2] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA
来源：
CANCER RESEARCH | 2005年 / 65卷 / 11期
关键词：
D O I：
10.1158/0008-5472.CAN-05-0559
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
It has been 25 years since the discovery of human T-cell leukemia virus type I (HTLV-1) and its role in adult T-cell leukemia. Here, in brief, we review the current state of our understanding of HTLV-1 epidemiology, viral biology, pathogenesis, and treatment. We discuss how HTLV-1 may transform cells through destabilization of cellular genomic integrity and induction of cellular tolerance for chromosomal errors.
引用
收藏
页码：4467 / 4470
页数：4
相关论文
共 54 条
[31]   Human T-cell leukemia virus type 1 Tax and cell cycle progression: Role of cyclin D-cdk and p110Rb [J].
Neuveut, C ;
Low, KG ;
Maldarelli, F ;
Schmitt, I ;
Majone, F ;
Grassmann, R ;
Jeang, KT .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (06) :3620-3632
[32]   Genome-wide expression changes induced by HTLV-1 Tax:: evidence for MLK-3 mixed lineage kinase involvement in Tax-mediated NF-κB activation [J].
Ng, PWP ;
Iha, H ;
Iwanaga, Y ;
Bittner, M ;
Chen, YD ;
Jiang, Y ;
Gooden, G ;
Trent, JM ;
Meltzer, P ;
Jeang, KT ;
Zeichner, SL .
ONCOGENE, 2001, 20 (33) :4484-4496
[33]   Mechanism of hypercalcemia in adult T-cell leukemia:: overexpression of receptor activator of nuclear factor κB ligand on adult T-cell leukemia cells [J].
Nosaka, K ;
Miyamoto, T ;
Sakai, T ;
Mitsuya, H ;
Suda, T ;
Matsuoka, M .
BLOOD, 2002, 99 (02) :634-640
[34]   Differential requirements for activation of integrated and transiently transfected human T-cell leukemia virus type 1 long terminal repeat [J].
Okada, M ;
Jeang, KT .
JOURNAL OF VIROLOGY, 2002, 76 (24) :12564-12573
[35]   Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma [J].
Okamura, J ;
Utsunomiya, A ;
Tanosaki, R ;
Uike, N ;
Sonoda, S ;
Kannagi, M ;
Tomonaga, M ;
Harada, M ;
Kimura, N ;
Masuda, M ;
Kawano, F ;
Yufu, Y ;
Hattori, H ;
Kikuchi, H ;
Saburi, Y .
BLOOD, 2005, 105 (10) :4143-4145
[36]  
Pise-Masison CA, 2002, CANCER RES, V62, P3562
[37]   DETECTION AND ISOLATION OF TYPE-C RETROVIRUS PARTICLES FROM FRESH AND CULTURED LYMPHOCYTES OF A PATIENT WITH CUTANEOUS T-CELL LYMPHOMA [J].
POIESZ, BJ ;
RUSCETTI, FW ;
GAZDAR, AF ;
BUNN, PA ;
MINNA, JD ;
GALLO, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (12) :7415-7419
[38]   Human T-cell leukemia virus type 2 Tax mutants that selectively abrogate NFκB or CREB/ATF activation fail to transform primary human T cells [J].
Ross, TM ;
Narayan, M ;
Fang, ZY ;
Minella, AC ;
Green, PL .
JOURNAL OF VIROLOGY, 2000, 74 (06) :2655-2662
[39]   Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro [J].
Satou, Y ;
Nosaka, K ;
Koya, Y ;
Yasunaga, J ;
Toyokuni, S ;
Matsuoka, M .
LEUKEMIA, 2004, 18 (08) :1357-1363
[40]   The oncoprotein tax binds the SRC-1-interacting domain of CBP/p300 to mediate transcriptional activation [J].
Scoggin, KES ;
Ulloa, A ;
Nyborg, JK .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (16) :5520-5530
123456